By Donna Mitchell-Magaldi, M.S., Nerac Analyst,
Originally Published: March 8, 2016
You have a great idea for an innovative product, a granted patent, and you are ready to assess market and commercialization feasibility. Do you know the important questions you will need to answer? Possibly the most important questions are: What are the regulatory pathways you will need to navigate in order to get your innovative product approved and on the market, and what are the potential financial burdens associated with compliance?
Want to read the rest of the article? Fill out the form to download:Commercialization Strategy for Innovative Products: The Importance of Considering Regulatory Implications
Related Posts
- 73By Donna Mitchell-Magaldi, Nerac Analyst, The global medical device market was valued at $350 billion dollars in 2012 (Mddonline.com, 2012). The US market was valued at $127 Billion dollars in 2013 making it the largest medical device market in the world (Prweb.com, 2013). However, millions of dollars are lost every year due to regulatory noncompliance issues…
- 69By Richard Conforti, M.S., Nerac Analyst, Originally Published: April-August, 2016 In 2014 the Chinese Food and Drug Administration, CFDA, updated their regulations on medical devices. These updates substantially changed the way in which a medical device company, particularly international companies not based or founded in China, registers their devices in China. In part 1 of…
- 69By Donna Mitchell-Magaldi, Nerac Analyst Originally Published: February 10, 2015 It is no surprise to anyone in the medical device industry that the European Commission is working on a new regulatory framework that will in essence take the three existing directives: Directive 90/385/EEC regarding active implantable medical devices, Directive 93/42/42 regarding medical devices, and Directive…